RNF213 and breast carcinoma: RNF213 contains AAA-ATPase and RING E3 ligase domains in the same molecule, is associated with MMD (Liu et al, 2011), and is required for the toxic effects of PTP1B deficiency/inhibition in hypoxic HER2+ breast cancer cells (Banh et al, 2016).